PARP1 and neoplasm: A recent study used a modified proximity ligation assay to detect chromatin-trapped PARP1 and concluded that PARP1 trapping correlated with cellular toxicity in both non-malignant and tumor cells, which may limit the therapeutic advantage of potent trapping activity.